Cardiac resynchronisation therapy (CRT) is the insertion of electrodes in the left and right ventricles of the heart, as well as on occasion the right atrium, to treat heart failure by coordinating the function of the left and right ventricles. CRT defibrillators (CRT-D) also incorporate the additional function of an implantable cardioverter-defibrillator (ICD), to quickly terminate an abnormally fast, life-threatening heart rhythm. CRT and CRT-D have become increasingly important therapeutic options for patients with moderate and severe heart failure.
This report contains market size and forecasts of Cardiac Resynchronization Therapy Defibrillators (CRT-Ds) in global, including the following market information:
Global Cardiac Resynchronization Therapy Defibrillators (CRT-Ds) Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Cardiac Resynchronization Therapy Defibrillators (CRT-Ds) Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Cardiac Resynchronization Therapy Defibrillators (CRT-Ds) companies in 2021 (%)
The global Cardiac Resynchronization Therapy Defibrillators (CRT-Ds) market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Implantable Cardioverter Defibrillator Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Cardiac Resynchronization Therapy Defibrillators (CRT-Ds) include Medtronic, Abbott, Boston Scientific, MicroPort Scientific, BIOTRONIK, Medico and LivaNova, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Cardiac Resynchronization Therapy Defibrillators (CRT-Ds) manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Cardiac Resynchronization Therapy Defibrillators (CRT-Ds) Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Cardiac Resynchronization Therapy Defibrillators (CRT-Ds) Market Segment Percentages, by Type, 2021 (%)
Implantable Cardioverter Defibrillator
External Defibrillator (ED)
Global Cardiac Resynchronization Therapy Defibrillators (CRT-Ds) Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Cardiac Resynchronization Therapy Defibrillators (CRT-Ds) Market Segment Percentages, by Application, 2021 (%)
Hospitals
Ambulatory Surgery Centers
Global Cardiac Resynchronization Therapy Defibrillators (CRT-Ds) Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Cardiac Resynchronization Therapy Defibrillators (CRT-Ds) Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Cardiac Resynchronization Therapy Defibrillators (CRT-Ds) revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Cardiac Resynchronization Therapy Defibrillators (CRT-Ds) revenues share in global market, 2021 (%)
Key companies Cardiac Resynchronization Therapy Defibrillators (CRT-Ds) sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Cardiac Resynchronization Therapy Defibrillators (CRT-Ds) sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Medtronic
Abbott
Boston Scientific
MicroPort Scientific
BIOTRONIK
Medico
LivaNova